We are live on ! Find out more
IFRX icon

InflaRx
IFRX

38 hedge funds and large institutions have $44.1M invested in InflaRx in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,307% more call options, than puts

Call options by funds: $5.58M | Put options by funds: $232K

92% more capital invested

Capital invested by funds: $23M → $44.1M (+$21.1M)

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

9% more funds holding

Funds holding: 35 → 38 (+3)

0.9% more ownership

Funds ownership: 20.09% → 20.99% (+0.9%)

40% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 10

Holders
38
Holders Change
+3
Holders Change %
+8.57%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
6
Reduced
10
Closed
8
Calls
$5.58M
Puts
$232K
Net Calls
+$5.35M
Net Calls Change
+$4.33M

Top Buyers

Rank Fund Capital Flow
1
SI
Sofinnova Investments
California
+$4.67M
2
Walleye Capital
Walleye Capital
New York
+$2.13M
3
Invesco
Invesco
Georgia
+$641K
4
Morgan Stanley
Morgan Stanley
New York
+$606K
5
GTCM
Gyon Technologies Capital Management
New Jersey
+$405K

Top Sellers

Rank Fund Capital Flow
1
DCM
DAFNA Capital Management
California
-$1.55M
2
GPP
Great Point Partners
Connecticut
-$1.43M
3
IC
Ikarian Capital
Texas
-$1.21M
4
FIA
FNY Investment Advisers
New York
-$876K
5
O
OrbiMed
New York
-$759K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Suvretta Capital Management
New York
$15.6M – – –
SI
2
Sofinnova Investments
California
$5.53M +$4.67M +1,161,736 New
O
3
OrbiMed
New York
$4.17M -$759K -188,821 -18%
Morgan Stanley
4
Morgan Stanley
New York
$4.16M +$606K +150,686 +21%
Walleye Capital
5
Walleye Capital
New York
$2.52M +$2.13M +530,432 New
LCM
6
Laurion Capital Management
New York
$2.38M – – –
IC
7
Ikarian Capital
Texas
$1.58M -$1.21M -300,000 -48%
KCM
8
Kingdon Capital Management
New York
$1.55M -$302K -75,000 -19%
Bank Julius Baer & Co
9
Bank Julius Baer & Co
Switzerland
$941K – – –
Invesco
10
Invesco
Georgia
$759K +$641K +159,396 New
GTCM
11
Gyon Technologies Capital Management
New Jersey
$479K +$405K +100,706 New
Renaissance Technologies
12
Renaissance Technologies
New York
$478K +$69.6K +17,310 +21%
FIA
13
FNY Investment Advisers
New York
$476K -$876K -218,000 -69%
RJFSA
14
Raymond James Financial Services Advisors
Florida
$455K +$329K +81,786 +589%
FSA
15
Franklin Street Advisors
North Carolina
$357K – – –
KWM
16
Kingsview Wealth Management
Oregon
$342K +$289K +71,870 New
BC
17
Birchview Capital
Vermont
$333K – – –
RJA
18
Raymond James & Associates
Florida
$312K +$222K +55,123 +529%
Two Sigma Investments
19
Two Sigma Investments
New York
$286K +$197K +49,099 +444%
Citadel Advisors
20
Citadel Advisors
Florida
$267K +$225K +56,074 New
BFM
21
Boothbay Fund Management
New York
$158K -$121K -30,112 -48%
MAM
22
Marquette Asset Management
Minnesota
$158K – – –
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$130K -$40.6K -10,103 -27%
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$129K +$109K +27,053 New
IIA
25
IPG Investment Advisors
California
$124K – – –
1
2

IFRX Hedge Fund Activity: Q4 2021 in Review

38 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q4 2021, worth a combined $44.1M — up 92% from $23M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new IFRX positions and 8 closed out — a net gain of 3 holders — while 6 added to existing stakes and 10 trimmed.

The largest buyer was Sofinnova Investments, opening a new position worth an estimated $4.67M. The largest seller was DAFNA Capital Management, exiting entirely with an estimated $1.55M sold.

  • 38 institutional investors held InflaRx (IFRX) as of Q4 2021, up from 35 in Q3 2021.
  • Funds reported $44.1M of InflaRx stock for Q4 2021, up 92% quarter-over-quarter.
  • 11 funds opened new InflaRx positions in Q4 2021 and 8 closed out, a net change of +3 holders.
  • The largest InflaRx buyer in Q4 2021 was Sofinnova Investments, an estimated $4.67M added.
  • The largest InflaRx seller in Q4 2021 was DAFNA Capital Management, an estimated $1.55M sold.

Based on aggregated 13F filings for Q4 2021.